ProQR Therapeutics NV
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About ProQR Therapeutics NV
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.
/ 
Frequently asked questions
To buy ProQR Therapeutics NV stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for ProQR Therapeutics NV by name or ticker, choose the number of shares, and place your order.
The ticker symbol for ProQR Therapeutics NV is PRQR:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
ProQR Therapeutics NV has its primary listing on NASDAQ. You can trade ProQR Therapeutics NV with a Saxo account, alongside thousands of other stocks worldwide.
Yes, ProQR Therapeutics NV is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include ProQR Therapeutics NV as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like ProQR Therapeutics NV.